H.R. 3884 — Engrossed in House

118th CONGRESS 2d Session H. R. 3884 AN ACT To amend title XI of the Public Health Service Act to reauthorize the program providing for sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment. 1. Short title This Act may be cited as the Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023. 2. Reauthorization of sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment Section 1106(b) of the Public Health Service Act (42 U.S.C. 300b–5(b)) is amended— (1) in paragraph (3)(A), by inserting , grant, or cooperative agreement after contract; and (2) in paragraph (6), by striking $4,455,000 for each of fiscal years 2019 through 2023 and inserting $8,205,000 for each of fiscal years 2024 through 2028. Passed the House of Representatives September 23, 2024.Clerk.